FDA Inspection 1290824 — Matrix Pharmacorp Private Limited

Matrix Pharmacorp Private Limited — FEI 3008861594

The FDA completed an inspection of Matrix Pharmacorp Private Limited on November 7, 2025 in Visakhapatnam. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Visakhapatnam (India)